PGT121.414.LS Clinical Trials
3 recruitingDrug
Phase 22Phase 12
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
The Tatelo Plus Study
HIV InfectionsHIV
National Institute of Allergy and Infectious Diseases (NIAID)41 enrolled2 locationsNCT06508749
Recruiting
Phase 1
Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1
HIV-1
National Institute of Allergy and Infectious Diseases (NIAID)48 enrolled17 locationsNCT06517693
Recruiting
Phase 2
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)48 enrolled36 locationsNCT05719441